Top Markets
#1 Islamic Coin Islamic Coin +152.27%
#2 Bitway Bitway +49.98%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +38.40%
#4 Starpower Starpower +33.78%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.43%
#6 Pons Pons +21.35%
#7 Decred Decred +20.90%
#8 aelf aelf +19.43%
#9 Pleasing Gold Pleasing Gold +17.80%
#10 Venom Venom +15.71%
Coin of the day
Islamic Coin Islamic Coin
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
Proteomics International Laboratories Ltd. Proteomics International Laboratories Ltd.

Proteomics International Laboratories Ltd.

PIQ
Xếp hạng trong cổ phiếu #30008
Proteomics International Laboratories Ltd operates as a medical technology... Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and Southeast Asia. It provides PromarkerD, a blood test to predict diabetic kidney disease (DKD). The company’s products under development include PromarkerEndo, which has completed clinical validation phase for endometriosis diagnosis; PromarkerEso, which has completed clinical validation trials for esophageal cancer diagnosis; and OxiDx (2-tag), which has completed clinical validation phase for oxidative stress treatment. It is also developing diagnostic tests for that includes DKD - T1D, that is under clinical phase for type 1 diabetes, diabetic retinopathy, and diabetic neuropathy; Asthma and COPD, which has completed proof-of-concept study trials for asthma and chronic obstructive pulmonary disease; Plant Dieback, that is under development phase for phytophthora dieback; Diabetic Retinopathy, which has completed discovery phase for sight-threatening retinopathy; and Diabetic Neuropathy, that is under research phase to investigate predictive biomarkers for diabetic neuropathy. The company also offers analytical services, such as specialist contract research focusing on biomarker discovery, biosimilars quality control, and pharmacokinetic testing for clinical trials. It has strategic collaboration with Harry Perkins Institute of Medical Research, Bioplatforms Australia, The University of Western Australia, Australian Research Council Training Centre, and the Australian Centre. Proteomics International Laboratories Ltd was founded in 2001 and is based in Perth, Australia.
Giá cổ phiếu
$0.11284557
Vốn hóa thị trường
$18.66M
Thay đổi (1 ngày)
3.23%
Thay đổi (1 năm)
-47.82%
Quốc gia
AU
Giao dịch Proteomics International Laboratories Ltd. (PIQ)

Danh mục

Healthcare
Lịch sử chia tách cổ phiếu của Proteomics International Laboratories Ltd. (PIQ)
Cổ phiếu Proteomics International Laboratories Ltd. (mã: PIQ) đã trải qua tổng cộng 0 lần chia tách.
Lần chia tách gần nhất diễn ra vào ngày Aug 19, 2026.
Một cổ phiếu PIQ mua trước ngày Aug 19, 2026 hiện tương đương với 0 cổ phiếu PIQ.
Danh sách chia tách cổ phiếu
Năm Chia tách Tỷ lệ Tỷ lệ cộng dồn
Không đủ dữ liệu cho ngày được cung cấp.
Chia tách cổ phiếu của các công ty tương tự hoặc đối thủ
Công ty Số lần chia tách cổ phiếu Tỷ lệ cộng dồn Quốc gia
HCA Healthcare, Inc. HCA Healthcare, Inc.
HCA Healthcare, Inc.
HCA.US
 0 -
US
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA
FRE.DE
 0 -
DE
Dr. Sulaiman Al Habib Medical Services Group Company Dr. Sulaiman Al Habib Medical Services Group Company
Dr. Sulaiman Al Habib Medical Services Group Company
4013.SR
 0 -
SA
Tenet Healthcare Corporation Tenet Healthcare Corporation
Tenet Healthcare Corporation
THC.US
 12 x7
US
IHH Healthcare Berhad IHH Healthcare Berhad
IHH Healthcare Berhad
5225.KL
 0 -
MY